Status:
COMPLETED
Influence of Chemotherapy on Postural Control in Women With Cancer
Lead Sponsor:
Aline Reinmann
Conditions:
Cancer, Breast
Cancer, Gynecologic
Eligibility:
FEMALE
18-65 years
Brief Summary
The aim of this study is to understand the strategies for adapting postural control in patients who have received chemotherapy treatment for gynaecological cancer.
Detailed Description
Chemotherapy can cause many side effects, including peripheral neuropathies. Chemotherapy induced peripheral neuropathies (CIPN) are primarily sensory impairments that can alter the signals for somato...
Eligibility Criteria
Inclusion
- Women
- between 18 and 65 years;
- with a gynaecological cancer about to start chemotherapy known to be neurotoxic (paclitaxel, docetaxel, nab-paclitaxel, or paclitaxel-carboplatin);
- able to stand upright for 30 s on a flat surface without assistance;
- able to provide written consent
Exclusion
- Women
- with pre-existing vestibular, uncorrectable visual, or somatosensory disorders or other pathologies altering postural control that would influence testing;
- with exposure to known neurotoxic chemotherapy (paclitaxel, docetaxel, nab-paclitaxel, vinorelbine, trastuzumab-emtansine, eribulin, or paclitaxel-carboplatin) that may have caused previous CIPN;
- with an inability to perform the test due to poor comprehension of instructions or psychological problems.
Key Trial Info
Start Date :
October 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04692168
Start Date
October 7 2020
End Date
December 31 2022
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Switzerland, 1205